What are the differences between Mixtard (premixed insulin containing 70% NPH and 30% regular insulin) and insulin lispro (rapid‑acting insulin analogue)?

Mixtard vs Insulin Lispro: Key Differences

Mixtard (70/30 NPH/regular insulin) is a premixed insulin with slower onset and longer duration requiring fixed meal timing, while insulin lispro is a rapid-acting analogue with faster onset (15 minutes) and shorter duration that offers greater meal flexibility and superior postprandial glucose control.

Pharmacokinetic Differences

Mixtard (70/30 NPH/Regular)

• Composition: 70% intermediate-acting NPH + 30% regular human insulin
• Onset: Regular component takes 30-60 minutes to act
• Peak: Dual peaks (regular at 2-4 hours, NPH at 4-10 hours)
• Duration: 10-16 hours total
• Timing: Must be given 30 minutes before meals 1

Insulin Lispro

• Composition: Rapid-acting insulin analogue (lysine at B28, proline at B29) 2
• Onset: ~15-17 minutes 2
• Peak: 1-2 hours (120 minutes for 7 units) 2
• Duration: 4-7 hours depending on dose 2
• Timing: Can be given immediately before or even during meals 3

Clinical Performance Differences

Postprandial Glucose Control

Insulin lispro provides significantly better postprandial glucose control than Mixtard. When lispro-containing premixes (75/25 or 50/50) were compared to human insulin 70/30:

• Lispro mixtures reduced 2-hour postprandial glucose by 14-54 mg/dL more than human insulin 70/30 4
• Peak glucose rise was 18-37 mg/dL lower with lispro-containing preparations 5
• Incremental glucose AUC was 36-56% smaller with lispro mixtures 5

HbA1c Control

Long-term glycemic control (HbA1c) is generally comparable between Mixtard and lispro-containing regimens in most studies, though postprandial control consistently favors lispro 6, 7.

Hypoglycemia Risk

Both preparations have similar rates of hypoglycemia in clinical trials, with major hypoglycemia being rare with either formulation 6, 7. However, lispro's shorter duration may reduce nocturnal hypoglycemia risk.

Practical Clinical Considerations

When to Choose Insulin Lispro

• Irregular meal schedules: Lispro offers flexibility in meal timing 1
• High postprandial glucose excursions: Lispro provides superior postprandial control 4, 5
• Asian patients or high-carbohydrate diets: May benefit more from rapid-acting coverage 8
• Patient preference for mealtime dosing: Can inject 0-15 minutes before eating 3

When Mixtard May Be Appropriate

• Cost constraints: Human insulin 70/30 is significantly less expensive than analogues 1
• Fixed meal schedules: Patients who eat consistent meals at regular times
• Simplicity preference: Single formulation covers both basal and prandial needs
• Already well-controlled: Patients stable on Mixtard should not be switched unnecessarily 3

Mixing Compatibility

Critical difference: Rapid-acting insulin lispro can be mixed with NPH insulin with only slight decrease in absorption rate but no change in total bioavailability 3. When mixed, the combination should be injected within 15 minutes before a meal 3.

Common Pitfalls to Avoid

1. Timing errors: Mixtard requires 30-minute pre-meal administration; lispro does not
2. Assuming equivalent dosing: When switching, doses may need adjustment based on individual response
3. Ignoring meal patterns: Lispro's flexibility advantage is lost if patient has fixed meal schedule
4. Cost blindness: The pharmacodynamic advantages of lispro may not justify the cost difference for all patients 1

Algorithm for Selection

Start with these questions:

1. Can patient afford analogue insulin? If no → Consider Mixtard
2. Does patient have irregular meal schedule? If yes → Choose lispro
3. Are postprandial glucose levels >180 mg/dL despite therapy? If yes → Choose lispro
4. Is patient already controlled on Mixtard? If yes → Continue Mixtard 3
5. Does patient need dosing flexibility? If yes → Choose lispro 1

The evidence strongly supports that while both insulins achieve similar HbA1c targets, insulin lispro provides superior postprandial glucose control with greater dosing flexibility, making it preferable when cost is not prohibitive 1, 4, 5.